Laboratory considerations on the use of F-18 myocardial perfusion imaging radiotracers: An Information Statement from the American Society of Nuclear Cardiology

IF 3 4区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Journal of Nuclear Cardiology Pub Date : 2025-06-01 DOI:10.1016/j.nuclcard.2025.102230

Rupa Sanghani MD (Co-chair) , Robert deKemp PhD (Co-chair) , Stephen Horgan MB, BCh, PhD (Co-chair) , Mouaz Al-Mallah MD , Timothy Bateman MD , James Case PhD , Panithaya Chareonthaitawee MD , Sharmila Dorbala MD, MPH , Gary Heller MD, PhD , Mark Hyun CNMT , Lawrence M. Phillips MD

引用次数: 0

Abstract Image

查看原文本刊更多论文

关于使用F-18心肌灌注成像放射性示踪剂的实验室考虑：来自美国核心脏病学会的信息声明

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Nuclear Cardiology 医学-核医学

CiteScore

5.30

自引率

20.80%

发文量

249

审稿时长

4-8 weeks

期刊介绍： Journal of Nuclear Cardiology is the only journal in the world devoted to this dynamic and growing subspecialty. Physicians and technologists value the Journal not only for its peer-reviewed articles, but also for its timely discussions about the current and future role of nuclear cardiology. Original articles address all aspects of nuclear cardiology, including interpretation, diagnosis, imaging equipment, and use of radiopharmaceuticals. As the official publication of the American Society of Nuclear Cardiology, the Journal also brings readers the latest information emerging from the Society''s task forces and publishes guidelines and position papers as they are adopted.